Skip to main content
. 2018 Jan 31;48(1):0300060517749111. doi: 10.1177/0300060517749111

Figure 4.

Figure 4.

Identification of risk in patients with target low-density lipoprotein (LDL) levels. Percentage of patients at guideline LDL target with positive myeloperoxidase (MPO) stratified by hemoglobin A1C (HbA1C) as a function of year tested.